000627 Hubei Biocause Pharmaceutical
- 2.60
- -0.27-9.41%
Hubei Biocause Pharmaceutical News
Tianmao Group: Announcement on Abnormal Stock Trading Fluctuations in Tianmao Industrial Group Co., Ltd.
Tianmao Group: Announcement on Abnormal Stock Trading Fluctuations in Tianmao Industrial Group Co., Ltd.
Tianmao Group: Announcement on Abnormal Stock Trading Fluctuations in Tianmao Industrial Group Co., Ltd.
Tianmao Group: Semi-Annual Report Board Resolution Announcement
Tianmao Group: Announcement of the resolution of the board of supervisors on the semi-annual report
Hubei Biocause Pharmaceutical: Statement and Commitment of the Independent Director Candidate (Zhang Xiaomiao) of Hubei Biocause Pharmaceutical
Hubei Biocause Pharmaceutical: Statement and Commitment of Independent Director Candidate (Jiang Haihua) of Hubei Biocause Pharmaceutical
Hubei Biocause Pharmaceutical: Shareholder Meeting Rules (August 2024)
Hubei Biocause Pharmaceutical: Statement and Commitment of the Independent Director Candidate of Hubei Biocause Pharmaceutical
Hubei Biocause Pharmaceutical: Statement and Commitment of Independent Director Candidate (Director Hu Bing) of Hubei Biocause Pharmaceutical
Hubei Biocause Pharmaceutical: Director, Supervisor, and Senior Management Compensation Management System (August 2024).
Hubei Biocause Pharmaceutical: Hubei Biocause Pharmaceutical Company Bylaws (August 2024)
Hubei Biocause Pharmaceutical: Announcement of the resolution of the 18th meeting of the 9th board of directors of Hubei Biocause Pharmaceutical Group.
Hubei Biocause Pharmaceutical: Rules of Procedure for the Supervisor Meeting (August 2024)
Hubei Biocause Pharmaceutical: Announcement of the resolution of the 9th 17th Supervisory Board Meeting of Hubei Biocause Pharmaceutical.
Hubei Biocause Pharmaceutical: Notice of the resolution of the 17th meeting of the 9th board of directors of Hubei Biocause Pharmaceutical Group.
Hubei Biocause Pharmaceutical: Board of directors announcement of Hubei Biocause Pharmaceutical on September 16th.
Hubei Biocause Pharmaceutical: Hubei Biocause Pharmaceutical's announcement for the decision of the supervisory board on September 16th.
Hubei Biocause Pharmaceutical: Legal Opinion of Tianmao Group's 2023 Annual Shareholders' Meeting
Hubei Biocause Pharmaceutical: 000627 Tianmao Group Investor Relations Management Information 20240517
Analysis
Price Target
No Data
